These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 308545)
1. BN rat myeloid leukemia transferred to the (LEW x BN)F1 rat. Vaughn WP; Burke PJ; Jung J J Natl Cancer Inst; 1978 Sep; 61(3):927-9. PubMed ID: 308545 [TBL] [Abstract][Full Text] [Related]
2. Drug induced host factors which stimulate growth of residual leukemia in Lewis x Brown Norway F1 (LEW-BN) rats. Burke PJ; Karp JE; Saylor PL Cancer Res; 1986 Apr; 46(4 Pt 1):1813-6. PubMed ID: 3485014 [TBL] [Abstract][Full Text] [Related]
3. Development of a cell kinetic approach to curative therapy of acute myelocytic leukemia in remission using the cell cycle-specific drug 1-beta-D-arabinofuranosylcytosine in a rat model. Vaughan WP; Burke PJ Cancer Res; 1983 May; 43(5):2005-9. PubMed ID: 6572561 [TBL] [Abstract][Full Text] [Related]
4. In vitro colony formation of transplantable rat leukemias in comparison with human acute myeloid leukemia. van Bekkum DW; van Oosterom P; Dicke KA Cancer Res; 1976 Mar; 36(3):941-6. PubMed ID: 1062232 [TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of a rat model for human acute myelocytic leukemia. Hagenbeek A; Martens AC Haematologica; 1980 Jun; 65(3):293-308. PubMed ID: 6778781 [No Abstract] [Full Text] [Related]
6. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis. Wegmann KW; Hinrichs DJ J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543 [TBL] [Abstract][Full Text] [Related]
7. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia. Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103 [TBL] [Abstract][Full Text] [Related]
8. A subline of the Brown Norway myeloid leukemia in the Lewis x Brown Norway rat: in vivo growth characteristics and development of an in vitro clonogenic assay. Wiley JM; Yeager AM; Johnson RJ; Lanotte M Int J Cell Cloning; 1989 Sep; 7(5):292-302. PubMed ID: 2788672 [TBL] [Abstract][Full Text] [Related]
9. Absence of transplantation tolerance and strong sensitization in the host after transplantation of spleen allografts in the (LEW X BN)F1 leads to lew strain combination. Gugenheim J; Charpentier B; Houssin D; Martin B; Martin E; Fries D; Bismuth H Transplantation; 1983 Oct; 36(4):470-1. PubMed ID: 6226138 [No Abstract] [Full Text] [Related]
10. F1 hybrid resistance to BN rat myelogenous leukemia parallels resistance to transplantation of normal BN bone marrow. Williams RM; Singer DE; Rodday P; Bennett M Leuk Res; 1980; 4(2):261-4. PubMed ID: 6997635 [No Abstract] [Full Text] [Related]
11. Role of non-RT1 genes in the response of rat lymphocytes to Mycoplasma arthritidis T cell mitogen, concanavalin A and phytohemagglutinin. Cole BC; Griffiths MM; Sullivan GJ; Ward JR J Immunol; 1986 Apr; 136(7):2364-9. PubMed ID: 3081642 [TBL] [Abstract][Full Text] [Related]
12. Monitoring of leukemia growth in a rat model using a highly sensitive assay for the detection of LacZ marked leukemic cells. Hendrikx PJ; Martens AC; Schultz FW; Visser JW; Hagenbeek A Leukemia; 1995 Nov; 9(11):1954-60. PubMed ID: 7475289 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of retinyl palmitate and cytarabine treatment in a slowly growing rat leukemia model. Wathne KO; Lie SO; Colly L In Vivo; 1988; 2(2):139-41. PubMed ID: 2979829 [TBL] [Abstract][Full Text] [Related]
14. Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease. Tutschka PJ; Berkowitz SD; Tuttle S; Klein J Transplant Proc; 1987 Feb; 19(1 Pt 3):2668-73. PubMed ID: 3547945 [No Abstract] [Full Text] [Related]
15. Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response. Burke PJ; Karp JE; Vaughan WP J Natl Cancer Inst; 1981 Sep; 67(3):529-38. PubMed ID: 6944525 [TBL] [Abstract][Full Text] [Related]
16. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells. Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518 [TBL] [Abstract][Full Text] [Related]
17. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease. Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919 [TBL] [Abstract][Full Text] [Related]
18. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes. Majoor GD; Van Breda Vriesman PJ Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632 [TBL] [Abstract][Full Text] [Related]
19. Establishment of an acute graft-versus-host disease model following liver transplantation in donor-dominant one-way major histocompatibility complex matching rats. Xue F; Chen W; Wang XG; Liang L; Bai XL; Wang LY; Wang HP; Liang TB Transplant Proc; 2009 Jun; 41(5):1914-20. PubMed ID: 19545756 [TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated transfer and expression of marker genes in the BN rat acute myelocytic leukemia model for the study of minimal residual disease (MRD). Yan Y; Martens AC; de Groot CJ; Hendrikx PJ; Valerio D; van Bekkum DW; Hagenbeek A Leukemia; 1993 Jan; 7(1):131-9. PubMed ID: 8418372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]